What is Lite Strategy, Inc.?
a clinical-stage pharmaceutical company, focuses on the development of novel and differentiated therapies for the treatment of cancer.
The story behind the price, the case for and against, and what could go wrong. Open a part to read it.
a clinical-stage pharmaceutical company, focuses on the development of novel and differentiated therapies for the treatment of cancer. It is also involved in holding Litecoin tokens as a primary reserve asset. The company is listed on the NASDAQ in USA, operating in the Healthcare sector, with a market capitalisation of 23.99M.
A short list of Biotechnology names that are close enough in size to make side-by-side comparison useful.